“智能化用药监测系统”的研发及体会  

Experience of Research & Development of the Intelligent Prescription Screening System

作　　者：翟晓波[1] 何志高[1] 文传民 

机构地区：[1]同济大学附属东方医院药学部,上海市200120 [2]大通医药信息技术有限公司,上海市201203

出　　处：《中国药房》2008年第35期2791-2794,共4页China Pharmacy

基　　金：上海市卫生局科研课题(2006087)

摘　　要：目的:利用信息技术减少可预防的药物不良事件。方法:研发"智能化用药监测系统",基于医院信息系统,实现"禁忌证"与患者的病情诊断、实验室检查结果、肌酐清除率相链接。结果:在随机抽取的1天的数据(包括5546张处方)中,该系统共审查出与实验室检查结果相关的"禁忌证"46条,与诊断相关的"禁忌证"28条,与肌酐清除率相关的"禁忌证"32条。结论:这种链接方式切实可行,当处方中出现违反"禁忌证"的药物时,能够被及时识别,而其临床作用有待实践检验。OBJECTIVE： To reduce the incidence of the preventable adverse drug events by using information technology. METHODS： The intelligent prescription screening system was developed and the hospital information system- based link between ＂contraindications＂ and diagnosis of patients, their laboratory results and creatinine clearances were realized. RESULTS： Of the total 5 546 prescriptions selected randomly within one day, 46 laboratory results - related, 28 diagnosis - related and 32 creatinine clearance- related contraindications were detected by the system. CONCLUSION： This link mode is practical in that those prescriptions that violating the contraindications can be found out by the system; however, the clinical effect of the intelligent prescription screening system remains to be proved.

关 键 词：智能化用药监测系统 禁忌证 诊断 实验室检查结果 肌酐清除率 

分 类 号：R952[医药卫生—药学] R969.3